SERF1B
gene geneOn this page
Also known as FAM2BH4F5C
Summary
SERF1B (small EDRK-rich factor 1B, HGNC:10756) is a protein-coding gene on chromosome 5q13.2, encoding Small EDRK-rich factor 1 (O75920). Positive regulator of amyloid protein aggregation and proteotoxicity.
This gene is part of a 500 kb inverted duplication on chromosome 5q13. This duplicated region contains at least four genes and repetitive elements which make it prone to rearrangements and deletions. The repetitiveness and complexity of the sequence have also caused difficulty in determining the organization of this genomic region. This gene is the centromeric copy which is identical to the telomeric copy. Alternatively spliced transcripts have been documented but it is unclear whether alternative splicing occurs for both the centromeric and telomeric copies of the gene. The gene encodes a protein of unknown function which bears low-level homology with the RNA-binding domain of matrin-cyclophilin, a protein which colocalizes with small nuclear ribonucleoproteins (snRNPs) and the SMN1 gene product.
Source: NCBI Gene 728492 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 2 total
- MANE Select transcript:
NM_022978
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:10756 |
| Approved symbol | SERF1B |
| Name | small EDRK-rich factor 1B |
| Location | 5q13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FAM2B, H4F5C |
| Ensembl gene | ENSG00000205572 |
| Ensembl biotype | protein_coding |
| Entrez | 728492 |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 5 protein_coding, 2 protein_coding_CDS_not_defined, 1 retained_intron
ENST00000380750, ENST00000380751, ENST00000503931, ENST00000506542, ENST00000507177, ENST00000513144, ENST00000514285, ENST00000515588
RefSeq mRNA: 2 — MANE Select: NM_022978
NM_001178087, NM_022978
CCDS: CCDS43326, CCDS54866
Canonical transcript exons
ENST00000380750 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002073573 | 70025251 | 70025458 |
| ENSE00002079213 | 70041524 | 70043113 |
| ENSE00003462712 | 70026407 | 70026515 |
Expression profiles
Bgee: expression breadth ubiquitous, 134 present calls, max score 92.75.
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| prefrontal cortex | UBERON:0000451 | 92.75 | gold quality |
| cortical plate | UBERON:0005343 | 91.62 | gold quality |
| frontal cortex | UBERON:0001870 | 90.95 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 90.33 | gold quality |
| left testis | UBERON:0004533 | 90.32 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 90.11 | gold quality |
| cerebral cortex | UBERON:0000956 | 89.95 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 89.66 | gold quality |
| testis | UBERON:0000473 | 89.58 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 89.44 | gold quality |
| putamen | UBERON:0001874 | 89.24 | gold quality |
| right testis | UBERON:0004534 | 88.79 | gold quality |
| nucleus accumbens | UBERON:0001882 | 88.72 | gold quality |
| primary visual cortex | UBERON:0002436 | 88.72 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 88.64 | gold quality |
| hypothalamus | UBERON:0001898 | 88.58 | gold quality |
| brain | UBERON:0000955 | 88.52 | gold quality |
| ganglionic eminence | UBERON:0004023 | 88.52 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 88.49 | gold quality |
| right frontal lobe | UBERON:0002810 | 88.33 | gold quality |
| caudate nucleus | UBERON:0001873 | 87.96 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 87.88 | gold quality |
| cerebellar cortex | UBERON:0002129 | 87.86 | gold quality |
| cerebellum | UBERON:0002037 | 87.85 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 87.64 | gold quality |
| substantia nigra | UBERON:0002038 | 87.58 | gold quality |
| Ammon’s horn | UBERON:0001954 | 87.05 | gold quality |
| ventricular zone | UBERON:0003053 | 86.97 | gold quality |
| temporal lobe | UBERON:0001871 | 86.88 | gold quality |
| amygdala | UBERON:0001876 | 86.86 | gold quality |
Single-cell (SCXA)
Detected in 4 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-134144 | yes | 29.13 |
| E-MTAB-6524 | no | 142.22 |
| E-MTAB-7316 | no | 36.66 |
| E-ANND-3 | no | 0.61 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
56 targeting SERF1B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-450A-1-3P | 100.00 | 69.33 | 1837 |
| HSA-MIR-4455 | 100.00 | 65.48 | 1587 |
| HSA-MIR-126-5P | 100.00 | 72.71 | 3180 |
| HSA-MIR-513A-5P | 100.00 | 69.77 | 2465 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-302E | 99.96 | 70.74 | 2669 |
| HSA-MIR-6508-5P | 99.92 | 70.67 | 2465 |
| HSA-MIR-106A-5P | 99.90 | 73.94 | 2683 |
| HSA-MIR-302A-3P | 99.89 | 71.23 | 1777 |
| HSA-MIR-302B-3P | 99.89 | 71.23 | 1777 |
| HSA-MIR-302C-3P | 99.89 | 71.20 | 1778 |
| HSA-MIR-302D-3P | 99.89 | 71.25 | 1777 |
| HSA-MIR-17-5P | 99.89 | 73.83 | 2665 |
| HSA-MIR-106B-5P | 99.88 | 74.72 | 2795 |
| HSA-MIR-20A-5P | 99.88 | 74.76 | 2769 |
| HSA-MIR-20B-5P | 99.88 | 74.01 | 2621 |
| HSA-MIR-519D-3P | 99.88 | 73.97 | 2607 |
| HSA-MIR-93-5P | 99.88 | 73.98 | 2606 |
| HSA-MIR-526B-3P | 99.88 | 74.06 | 2587 |
| HSA-MIR-8067 | 99.86 | 69.59 | 2260 |
| HSA-MIR-373-3P | 99.84 | 70.68 | 1668 |
| HSA-MIR-520E-3P | 99.84 | 70.55 | 1698 |
| HSA-MIR-372-3P | 99.83 | 70.58 | 1691 |
| HSA-MIR-520A-3P | 99.83 | 70.59 | 1687 |
| HSA-MIR-520B-3P | 99.83 | 70.56 | 1699 |
| HSA-MIR-520C-3P | 99.83 | 70.56 | 1699 |
| HSA-MIR-520D-3P | 99.83 | 70.78 | 1676 |
Cross-species orthologs
0 orthologs
Paralogs (1): SERF1A (ENSG00000172058)
Protein
Protein identifiers
Small EDRK-rich factor 1 — O75920 (reviewed: O75920)
Alternative names: Protein 4F5, SMA modifier 1
All UniProt accessions (4): D6RC42, D6RC90, D6RCL9, O75920
UniProt curated annotations — full annotation on UniProt →
Function. Positive regulator of amyloid protein aggregation and proteotoxicity. Induces conformational changes in amyloid proteins, such as APP, HTT, and SNCA, driving them into compact formations preceding the formation of aggregates.
Subunit / interactions. Interacts with SNCA; this interaction promotes the aggregation of SNCA.
Subcellular location. Cytoplasm. Cytosol. Nucleus.
Tissue specificity. Isoform Long is predominantly expressed in heart, brain and skeletal muscle. Isoform Short and Isoform Long are expressed throughout the central nervous system, including spinal cord.
Similarity. Belongs to the SERF family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| O75920-1 | Long | yes |
| O75920-2 | Short |
RefSeq proteins (2): NP_001171558, NP_075267* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR007513 | SERF-like_N | Domain |
| IPR040211 | SERF1/2-like | Family |
Pfam: PF04419
UniProt features (17 total): mutagenesis site 11, region of interest 2, compositionally biased region 2, chain 1, splice variant 1
Structure
Experimental structures (PDB)
2 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 9M27 | SOLUTION NMR | |
| 9M2D | SOLUTION NMR |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-O75920-F1 | 63.77 | 0.00 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Mutagenesis-validated functional residues (11):
| Position | Phenotype |
|---|---|
| 13 | inhibits snca binding. |
| 14 | decreases snca binding. |
| 16 | drastically decreases snca binding. |
| 16 | inhibits snca binding. |
| 17 | drastically decreases snca binding. |
| 17 | inhibits snca binding. |
| 18 | no effect on snca binding. |
| 11 | no effect on snca binding. |
| 11 | decreases snca binding. |
| 12 | slightly decreases snca binding. |
| 13 | decreases snca binding. |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 36 (showing top):
GOBP_PROTEIN_DESTABILIZATION, GOBP_REGULATION_OF_PROTEIN_STABILITY, DANG_BOUND_BY_MYC, BENPORATH_MYC_MAX_TARGETS, GOBP_SUPRAMOLECULAR_FIBER_ORGANIZATION, FORTSCHEGGER_PHF8_TARGETS_UP, GOBP_AMYLOID_FIBRIL_FORMATION, MIR616_5P, MIR371B_5P, MIR373_5P, MIR106B_5P, MIR20A_5P, MIR106A_5P, MIR17_5P, MIR561_3P
GO Biological Process (3): nervous system development (GO:0007399), protein destabilization (GO:0031648), amyloid fibril formation (GO:1990000)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (5): nucleus (GO:0005634), cytosol (GO:0005829), protein-containing complex (GO:0032991), cytoplasm (GO:0005737), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| system development | 1 |
| regulation of protein stability | 1 |
| protein metabolic process | 1 |
| supramolecular fiber organization | 1 |
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| cytoplasm | 1 |
| cellular_component | 1 |
| intracellular anatomical structure | 1 |
Protein interactions and networks
STRING
380 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SERF1B | NDUFAF3 | Q9BU61 | 919 |
| SERF1B | NAIP | Q13075 | 872 |
| SERF1B | SMN1 | Q16637 | 839 |
| SERF1B | GPKOW | Q92917 | 724 |
| SERF1B | C1S | P09871 | 720 |
| SERF1B | BDP1 | A6H8Y1 | 688 |
| SERF1B | TAAR8 | Q969N4 | 605 |
| SERF1B | GTF2H2 | Q13888 | 599 |
| SERF1B | TPMT | P51580 | 592 |
| SERF1B | GTF2H2C | Q6P1K8 | 583 |
| SERF1B | CD82 | P27701 | 582 |
| SERF1B | TAAR6 | Q96RI8 | 517 |
| SERF1B | BACE1 | P56817 | 507 |
| SERF1B | PLS3 | P13797 | 491 |
| SERF1B | ZNF77 | Q15935 | 479 |
IntAct
44 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MED4 | MED19 | psi-mi:“MI:0914”(association) | 0.900 |
| SERF1A | TIMMDC1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SERF1A | CERS4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SERF1A | ELOVL7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SERF1A | AQP6 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SERF1A | REEP4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ELOVL7 | SERF1A | psi-mi:“MI:0915”(physical association) | 0.560 |
| SERF1A | TMX2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SERF1A | TMEM14B | psi-mi:“MI:0915”(physical association) | 0.560 |
| SERF1A | CRB3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SERF1A | ABHD16A | psi-mi:“MI:0915”(physical association) | 0.560 |
| SERF1A | RNASEK | psi-mi:“MI:0915”(physical association) | 0.560 |
| SERF1A | ELOVL4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SERF1A | GPR152 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SERF1A | LRRK2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| SERF1A | SRPK2 | psi-mi:“MI:0217”(phosphorylation reaction) | 0.440 |
| SRPK1 | SERF1A | psi-mi:“MI:0217”(phosphorylation reaction) | 0.440 |
| SERF1A | SMC2 | psi-mi:“MI:0914”(association) | 0.350 |
| PIK3R3 | SERF1A | psi-mi:“MI:0915”(physical association) | 0.000 |
| SERF1A | TMX2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| SERF1A | TMEM14B | psi-mi:“MI:0915”(physical association) | 0.000 |
| SERF1A | CRB3 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (33): SERF1A (Affinity Capture-MS), SERF1A (Reconstituted Complex), SERF1A (Affinity Capture-RNA), SERF1A (Two-hybrid), SERF1B (Two-hybrid), SERF1A (Two-hybrid), SERF1B (Two-hybrid), SERF1A (Two-hybrid), SERF1B (Two-hybrid), SERF1A (Two-hybrid), SERF1B (Two-hybrid), SERF1A (Two-hybrid), SERF1B (Two-hybrid), SERF1A (Two-hybrid), SERF1B (Two-hybrid)
ESM2 similar proteins: A6NC05, O13533, O13579, O71190, O75920, P0DM64, P0DO27, P12913, P38161, P38808, P38864, P43151, P47126, P53105, P53908, P76163, Q04502, Q08927, Q12169, Q12307, Q13536, Q16612, Q3E751, Q3Y452, Q495C1, Q4R541, Q53S99, Q5NVD3, Q69UP7, Q6B0X1, Q6DN03, Q6Q5F3, Q6Z2K1, Q6ZS49, Q6ZS62, Q6ZS92, Q70YC4, Q8BCV4, Q8FIP8, Q8N0U6
Diamond homologs: A5JSS4, B1MTI8, O75920, O88892, P84101, P84102, Q32P76, Q5R7C4, Q9BKU8, Q9VEW2, Q3E7B7
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
2 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
607 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 5:70026513:GAG:G | donor_gain | 1.0000 |
| 5:70026516:GT:G | donor_loss | 1.0000 |
| 5:70025374:T:TA | donor_gain | 0.9900 |
| 5:70025375:G:GA | donor_gain | 0.9900 |
| 5:70025379:ACG:A | donor_gain | 0.9900 |
| 5:70025434:GC:G | donor_gain | 0.9900 |
| 5:70025444:T:TA | donor_gain | 0.9900 |
| 5:70025445:G:GA | donor_gain | 0.9900 |
| 5:70025459:G:GG | donor_gain | 0.9900 |
| 5:70026405:A:AC | acceptor_loss | 0.9900 |
| 5:70026406:GGT:G | acceptor_gain | 0.9900 |
| 5:70026516:G:GG | donor_gain | 0.9900 |
| 5:70032310:TGTA:T | acceptor_loss | 0.9900 |
| 5:70032311:GTA:G | acceptor_loss | 0.9900 |
| 5:70032312:TA:T | acceptor_loss | 0.9900 |
| 5:70032313:A:AG | acceptor_gain | 0.9900 |
| 5:70032313:A:T | acceptor_loss | 0.9900 |
| 5:70032313:AG:A | acceptor_gain | 0.9900 |
| 5:70032314:G:GG | acceptor_gain | 0.9900 |
| 5:70032314:GG:G | acceptor_gain | 0.9900 |
| 5:70025454:GGCCC:G | donor_gain | 0.9800 |
| 5:70025455:GCCC:G | donor_gain | 0.9800 |
| 5:70025455:GCCCG:G | donor_gain | 0.9800 |
| 5:70026405:A:AG | acceptor_gain | 0.9800 |
| 5:70026405:AGGT:A | acceptor_gain | 0.9800 |
| 5:70026406:G:GG | acceptor_gain | 0.9800 |
| 5:70026406:GGTG:G | acceptor_gain | 0.9800 |
| 5:70032313:AGG:A | acceptor_gain | 0.9800 |
| 5:70032314:GGG:G | acceptor_gain | 0.9800 |
| 5:70032314:GGGA:G | acceptor_gain | 0.9800 |
AlphaMissense
725 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1003334033 (5:70028432 A>C), RS1004741285 (5:70036325 G>A), RS1004795241 (5:70032255 C>G), RS1010920459 (5:70037914 C>G), RS1011434092 (5:70036547 A>G,T), RS1012427821 (5:70041082 G>A), RS1012787687 (5:70043498 T>G), RS1013763284 (5:70031507 G>A), RS1015527914 (5:70032348 A>G), RS1015581845 (5:70029535 C>T), RS1022448670 (5:70036901 A>G), RS1023284941 (5:70038139 G>C), RS1024281922 (5:70041089 C>T), RS1027549024 (5:70029284 C>A,T), RS1027908605 (5:70032130 T>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
12 total (human), top 12 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Aflatoxin B1 | decreases methylation, increases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| chloropicrin | increases expression | 1 |
| ICG 001 | decreases expression | 1 |
| Grape Seed Proanthocyanidins | affects cotreatment, increases expression | 1 |
| theaflavin-3,3’-digallate | affects expression | 1 |
| Benzo(a)pyrene | increases expression | 1 |
| Catechin | affects cotreatment, increases expression | 1 |
| Smoke | decreases expression | 1 |
| Valproic Acid | decreases methylation | 1 |
| Sodium Selenite | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.